Esthesioneuroblastoma (ENB) is a rare type of cancer that affects the nasal cavity and the area around the eyes. It is a type of neuroendocrine tumor that arises from the olfactory epithelium, which is the tissue that lines the nasal cavity and is responsible for the sense of smell. Symptoms of ENB include nasal obstruction, facial pain, and loss of smell. Treatment typically involves surgery, radiation therapy, and chemotherapy.

Esthesioneuroblastoma is a rare type of cancer that affects the nasal cavity and the area around the eyes. Symptoms of Esthesioneuroblastoma can include:

-Nasal obstruction or congestion

-Nosebleeds

-Facial Pain or pressure
-Headaches
-Loss of smell
-Vision changes
-Facial swelling
-Facial numbness
-Facial paralysis
-Coughing
-Hoarseness
-Ear pain

Esthesioneuroblastoma is a rare type of cancer that affects the nasal cavity and the area around the eyes. The exact cause of this cancer is unknown, but some risk factors have been identified. These include exposure to certain chemicals, such as formaldehyde, and a family history of the disease. Other possible causes include genetic mutations, radiation exposure, and certain viruses.

The treatment for Esthesioneuroblastoma depends on the size and location of the tumor, as well as the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these treatments. Surgery is usually the first line of treatment and may involve removing the tumor and some of the surrounding tissue. Radiation therapy may be used to shrink the tumor before or after surgery. Chemotherapy may be used to shrink the tumor before or after surgery, or as a stand-alone treatment. In some cases, a combination of treatments may be used.

1. Exposure to wood dust: Studies have shown that exposure to wood dust, particularly from sawing and sanding, may increase the risk of developing Esthesioneuroblastoma.

2. Age: Esthesioneuroblastoma is more common in adults, with the majority of cases occurring in people between the ages of 40 and 70.

3. Gender: Esthesioneuroblastoma is more common in males than females.

4. Family history: A family history of Esthesioneuroblastoma may increase the risk of developing the disease.

5. Exposure to radiation: Exposure to radiation, such as radiation therapy for other cancers, may increase the risk of developing Esthesioneuroblastoma.

At this time, there is no known cure for Esthesioneuroblastoma. Treatment typically involves a combination of surgery, radiation therapy, and chemotherapy. Depending on the stage of the cancer, some patients may also receive targeted therapy or immunotherapy.